Wirth T, Parker N, Yla-Herttuala S. History of gene therapy. Gene. 2013;525:162–9.
Google Scholar
Gaudet D, Methot J, Kastelein J. Gene therapy for lipoprotein lipase deficiency. Curr Opin Lipidol. 2012;23:310–20.
Google Scholar
Dias MF, Joo K, Kemp JA, Fialho SL, da Silva Cunha A Jr., Woo SJ, et al. Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives. Prog Retin Eye Res. 2018;63:107–31.
Google Scholar
Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713–22.
Google Scholar
Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–78.
Google Scholar
Lecomte E, Tournaire B, Cogné B, Dupont J-B, Lindenbaum P, Martin-Fontaine M, et al. Advanced characterization of DNA molecules in rAAV vector preparations by single-stranded virus next-generation sequencing. Mol Ther Nucleic Acids. 2015;4:e260–e.
Google Scholar
Fan M, Guerin K, Rego M, Bourges D, Ersing I, Haery L, et al. A novel next generation sequencing and analysis platform to assess the identity of rAAV preparations from rAAV DNA extracts. Hum Gene Ther. 2020. https://doi.org/10.1089/hum.2019.277.
Xie J, Mao Q, Tai PWL, He R, Ai J, Su Q, et al. Short DNA hairpins compromise recombinant adeno-associated virus genome homogeneity. Mol Ther. 2017;25:1363–74.
Google Scholar
Tai PWL, Xie J, Fong K, Seetin M, Heiner C, Su Q, et al. Adeno-associated virus genome population sequencing achieves full vector genome resolution and reveals human-vector chimeras. Mol Ther Methods Clin Dev. 2018;9:130–41.
Google Scholar
Musatov S, Roberts J, Pfaff D, Kaplitt M. A cis-acting element that directs circular adeno-associated virus replication and packaging. J Virol. 2002;76:12792–802.
Google Scholar
Ling C, Wang Y, Lu Y, Wang L, Jayandharan GR, Aslanidi GV, et al. Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo. J Virol. 2015;89:952–61.
Google Scholar
Zhou Q, Tian W, Liu C, Lian Z, Dong X, Wu X. Deletion of the B-B’ and C-C’ regions of inverted terminal repeats reduces rAAV productivity but increases transgene expression. Sci Rep. 2017;7:5432.
Google Scholar
Matsushita T, Okada T, Inaba T, Mizukami H, Ozawa K, Colosi P. The adenovirus E1A and E1B19K genes provide a helper function for transfection-based adeno-associated virus vector production. J Gen Virol. 2004;85:2209–14.
Google Scholar
Lock M, Alvira M, Vandenberghe LH, Samanta A, Toelen J, Debyser Z, et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther. 2010;21:1259–71.
Google Scholar
Tomono T, Hirai Y, Okada H, Adachi K, Ishii A, Shimada T, et al. Ultracentrifugation-free chromatography-mediated large-scale purification of recombinant adeno-associated virus serotype 1 (rAAV1). Mol Ther Methods Clin Dev. 2016;3:15058.
Tomono T, Hirai Y, Okada H, Miyagawa Y, Adachi K, Sakamoto S, et al. Highly efficient ultracentrifugation-free chromatographic purification of recombinant AAV serotype 9. Mol Ther Methods Clin Dev. 2018;11:180–90.
Google Scholar
Tomono T, Hirai Y, Chono H, Mineno J, Ishii A, Onodera M, et al. Infectivity assessment of recombinant adeno-associated virus and wild-type adeno-associated virus exposed to various diluents and environmental conditions. Hum Gene Ther Methods. 2019;30:137–43.
Google Scholar
Okada T, Shimazaki K, Nomoto T, Matsushita T, Mizukami H, Urabe M, et al. Adeno-associated viral vector-mediated gene therapy of ischemia-induced neuronal death. Methods Enzymol. 2002;346:378–93.
Google Scholar
Sambrook J, Russell DW. Alkaline agarose gel electrophoresis. CSH Protoc. 2006;2006:pdb.prot4027.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.
Google Scholar
Brister JR, Muzyczka N. Rep-mediated nicking of the adeno-associated virus origin requires two biochemical activities, DNA helicase activity and transesterification. J Virol. 1999;73:9325–36.
Google Scholar
Chandler M, de la Cruz F, Dyda F, Hickman AB, Moncalian G, Ton-Hoang B. Breaking and joining single-stranded DNA: the HUH endonuclease superfamily. Nat Rev Microbiol. 2013;11:525–38.
Google Scholar
Burnham B, Nass S, Kong E, Mattingly M, Woodcock D, Song A, et al. Analytical ultracentrifugation as an approach to characterize recombinant adeno-associated viral vectors. Hum Gene Ther Methods. 2015;26:228–42.
Google Scholar
Hauck B, Murphy SL, Smith PH, Qu G, Liu X, Zelenaia O, et al. Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responses. Mol Ther. 2009;17:144–52.
Google Scholar
Gao K, Li M, Zhong L, Su Q, Li J, Li S, et al. Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side-effects. Mol Ther Methods Clin Dev. 2014;1:20139.
Google Scholar
Ren L, Ding S, Song Y, Li B, Ramanathan M, Co J, et al. Profiling of rotavirus 3’UTR-binding proteins reveals the ATP synthase subunit ATP5B as a host factor that supports late-stage virus replication. J Biol Chem. 2019;294:5993–6006.
Google Scholar
Zheng SQ, Li YX, Zhang Y, Li X, Tang H. MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res. 2011;89:219–26.
Google Scholar
Leng Q, Woodle MC, Lu PY, Mixson AJ. Advances in systemic siRNA delivery. Drugs Future. 2009;34:721.
Google Scholar
Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet. 2020;21:255–72.
Google Scholar
